ZA992478B - Adjuvant-containing dna vaccines. - Google Patents

Adjuvant-containing dna vaccines.

Info

Publication number
ZA992478B
ZA992478B ZA9902478A ZA992478A ZA992478B ZA 992478 B ZA992478 B ZA 992478B ZA 9902478 A ZA9902478 A ZA 9902478A ZA 992478 A ZA992478 A ZA 992478A ZA 992478 B ZA992478 B ZA 992478B
Authority
ZA
South Africa
Prior art keywords
adjuvant
containing dna
dna vaccines
vaccines
dna
Prior art date
Application number
ZA9902478A
Other languages
English (en)
Inventor
Jean-Christephe Franc Audonnet
Jules Maarten Minke
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9525029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA992478(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Sas filed Critical Merial Sas
Publication of ZA992478B publication Critical patent/ZA992478B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9902478A 1998-04-03 1999-03-31 Adjuvant-containing dna vaccines. ZA992478B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804409A FR2776928B1 (fr) 1998-04-03 1998-04-03 Vaccins adn adjuves

Publications (1)

Publication Number Publication Date
ZA992478B true ZA992478B (en) 2000-10-10

Family

ID=9525029

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902478A ZA992478B (en) 1998-04-03 1999-03-31 Adjuvant-containing dna vaccines.

Country Status (17)

Country Link
US (1) US7163926B1 (de)
EP (1) EP1066055B1 (de)
JP (1) JP2002510651A (de)
AR (1) AR037062A1 (de)
AT (1) ATE353670T1 (de)
AU (1) AU744964B2 (de)
BR (1) BR9909342A (de)
CA (1) CA2327389C (de)
CY (1) CY1108013T1 (de)
DE (1) DE69935136T2 (de)
DK (1) DK1066055T3 (de)
ES (1) ES2283105T3 (de)
FR (1) FR2776928B1 (de)
PL (1) PL194348B1 (de)
PT (1) PT1066055E (de)
WO (1) WO1999051269A1 (de)
ZA (1) ZA992478B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804026B1 (fr) * 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
US6551598B2 (en) 2000-01-21 2003-04-22 Merial Vaccination against canine herpesvirosis and vaccines therefor
EP1474153A4 (de) * 2001-12-14 2005-12-14 Genetronics Inc Verfahren zur partikelunterstützten polynukleotidimmunisierung mit einem gepulsten elektrischen feld
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
UA100370C2 (uk) 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
GB0805356D0 (en) * 2008-03-25 2008-04-30 Isis Innovation Vaccine adjuvant composition
CN103768588A (zh) 2008-05-08 2014-05-07 梅里亚有限公司 使用白蛉唾液免疫原的利什曼原虫疫苗
AP3334A (en) * 2008-10-24 2015-07-31 Univ California Vaccine against african horse sickness virus
SI2734230T1 (sl) 2011-07-20 2019-04-30 Merial Limited Rekombinantno cepivo proti virusu mačje levkemije, ki vsebuje optimiziran gen ovojnice virusa mačje levkemije
WO2013106558A1 (en) 2012-01-10 2013-07-18 Merial Limited Lipid based adjuvants for dna - plasmid vaccines
AU2013235423B2 (en) 2012-03-20 2017-03-30 Boehringer Ingelheim Animal Health USA Inc. Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
CN104717976A (zh) 2012-08-30 2015-06-17 梅里亚有限公司 嵌合ksac蛋白的表达和由高压产生可溶性蛋白的方法
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
CA3027877A1 (en) 2016-06-17 2017-12-21 Merial, Inc. Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
KR20230037034A (ko) * 2020-07-07 2023-03-15 아미리스 인코퍼레이티드 백신 면역증강제 그리고 이를 합성하는 방법 및 사용하는 방법
CN114272368A (zh) * 2021-12-16 2022-04-05 成都博宠生物科技有限公司 一种猪瘟和猪伪狂犬二联疫苗及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
ZA881694B (en) * 1987-03-17 1988-09-06 Akzo N.V. Adjuvant mixture
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (de) * 1991-05-28 1993-03-24 Miles Inc. Pferde-Rhinopneumonitis Impfstoff
ATE259417T1 (de) * 1992-06-01 2004-02-15 Univ Melbourne Immunologisches verfahren für die detektion von pferde-herpesvirus typ 1 und 4 glycoprotein g antikörper
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) * 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
GB9623051D0 (en) * 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP0991767A1 (de) * 1997-06-11 2000-04-12 Institut Pasteur Abgeschwächte rekombinante mycobacterien, die immunogene oder als impfstoff nützlich sind
AU8392898A (en) * 1997-07-14 1999-02-10 Powerject Vaccines, Inc. Method of dna vaccination using dna encoding antigen and encoding il6
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof

Also Published As

Publication number Publication date
FR2776928A1 (fr) 1999-10-08
DE69935136T2 (de) 2007-11-29
WO1999051269A1 (fr) 1999-10-14
BR9909342A (pt) 2000-12-12
PT1066055E (pt) 2007-05-31
CA2327389C (en) 2011-06-14
EP1066055A1 (de) 2001-01-10
AU2844899A (en) 1999-10-25
CY1108013T1 (el) 2013-09-04
DK1066055T3 (da) 2007-06-11
CA2327389A1 (en) 1999-10-14
DE69935136D1 (de) 2007-03-29
ATE353670T1 (de) 2007-03-15
ES2283105T3 (es) 2007-10-16
JP2002510651A (ja) 2002-04-09
AR037062A1 (es) 2004-10-20
AU744964B2 (en) 2002-03-07
US7163926B1 (en) 2007-01-16
FR2776928B1 (fr) 2000-06-23
EP1066055B1 (de) 2007-02-14
PL194348B1 (pl) 2007-05-31
PL343602A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
HK1047697A1 (en) Immunostimulatory nucleic acids.
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
HUP0201438A3 (en) Dna vaccine - pcv
ZA992478B (en) Adjuvant-containing dna vaccines.
GB9812613D0 (en) Vaccine
ZA973642B (en) DNA vaccine formulations.
DE69833112D1 (en) Rna polymerase
ZA987662B (en) Neospora Vaccine.
GB9822714D0 (en) Vaccines
IL139467A0 (en) Vaccine
GB9817909D0 (en) DNA constructs
GB9812674D0 (en) Nucleic acids
ZA98830B (en) Infectious bursitis vaccine.
MXPA01010701A (es) Vacuna.
GB9905644D0 (en) Dna
GB9826647D0 (en) DNA vaccines
ZA200006160B (en) Vaccine.
ZA99872B (en) Vaccine.
ZA987303B (en) Vaccine.
GB9821821D0 (en) Schistomiasis vaccine
GB9820956D0 (en) Vaccine
GB9812822D0 (en) Dna
GB9806702D0 (en) Dna